Please login to the form below

Not currently logged in
Email:
Password:

behavioural insights

This page shows the latest behavioural insights news and features for those working in and with pharma, biotech and healthcare.

Syneos Health announces partnership with AiCure

Syneos Health announces partnership with AiCure

The partnership will see AiCure leverage Syneos’ behavioural insights-driven product development model, with the aim to capture, analyse and predict patient behaviours influencing clinical trial adherence. ... The AiCure platform aligns with our unique

Latest news

  • INC Research/InVentiv Health becomes Syneos Health INC Research/InVentiv Health becomes Syneos Health

    More specifically, the company - which becomes the second largest outsourcing provider after IQVIA - combines behavioural insights to accelerate clinical trial recruitment and therapeutic know-how with multi-channel commercial programs to

  • Behaviour change needs a quantified approach Behaviour change needs a quantified approach

    Putting behaviour change into action. The pharmaceutical sector has taken great strides in adopting health psychology and behavioural economics insights over the past decade. ... As new research emerges, we can evolve and build on this model so that the

  • The potential of programmatic The potential of programmatic

    Greater data and insights. Data is at the heart of the programmatic process. ... Media buying is increasingly informed by location intelligence, which has become a source of real-world behavioural insights.And, as a result of having grown up in the

  • Turning healthcare on its head Turning healthcare on its head

    If pharma companies can leverage that desire, they can unlock patient insights that will drive meaningful behavioural change.”. ... These insights are likely to be the foundation of securing positive health behaviours.

  • Pragmatic digital health Pragmatic digital health

    These will be manifest not just in the provision of individual diagnoses but in deeper insights into the use of personalised medicines, ie the segmentation of patients who are more and ... is master practitioner, behavioural insights at Cello Health

More from news
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 15 partially matching documents found.

Latest appointments

  • Syneos Health Communications announces senior hires to Europe-based team Syneos Health Communications announces senior hires to Europe-based team

    Syneos Health Communications is the portfolio of Syneos Health agencies dedicated to delivering insights-driven integrated communications, working across advertising &branding, public relations and medical communications. ... The new team members will

  • Prime Global expands Core’s senior team Prime Global expands Core’s senior team

    Prior to his new role, Brunhuber served as head of medical strategy for Havas SO where he launched a start-up agency within the Havas network combining behavioural science and health ... psychology insights to develop promotional campaigns for

  • Orrin Pollard joins behavioural change agency Hamell Orrin Pollard joins behavioural change agency Hamell

    This is a step forward for Hamell and comes hot on the heels of some major new business wins in behavioural research. ... We are excited to be growing our full service agency and translating more of our in-depth behavioural insights into communications

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 21 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oxford University Press

Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...